BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25331958)

  • 21. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model.
    Sandhu SK; Volinia S; Costinean S; Galasso M; Neinast R; Santhanam R; Parthun MR; Perrotti D; Marcucci G; Garzon R; Croce CM
    Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20047-52. PubMed ID: 23169640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative splicing generates a short BCL6 (BCL6S) isoform encoding a compact repressor.
    Shen Y; Ge B; Ramachandrareddy H; McKeithan T; Chan WC
    Biochem Biophys Res Commun; 2008 Oct; 375(2):190-3. PubMed ID: 18675787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCL6 positively regulates AID and germinal center gene expression via repression of miR-155.
    Basso K; Schneider C; Shen Q; Holmes AB; Setty M; Leslie C; Dalla-Favera R
    J Exp Med; 2012 Dec; 209(13):2455-65. PubMed ID: 23166356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T follicular helper cells restricted by IRF8 contribute to T cell-mediated inflammation.
    Zhang R; Qi CF; Hu Y; Shan Y; Hsieh YP; Xu F; Lu G; Dai J; Gupta M; Cui M; Peng L; Yang J; Xue Q; Chen-Liang R; Chen K; Zhang Y; Fung-Leung WP; Mora JR; Li L; Morse HC; Ozato K; Heeger PS; Xiong H
    J Autoimmun; 2019 Jan; 96():113-122. PubMed ID: 30241692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A BCL6/BCOR/SIRT1 complex triggers neurogenesis and suppresses medulloblastoma by repressing Sonic Hedgehog signaling.
    Tiberi L; Bonnefont J; van den Ameele J; Le Bon SD; Herpoel A; Bilheu A; Baron BW; Vanderhaeghen P
    Cancer Cell; 2014 Dec; 26(6):797-812. PubMed ID: 25490446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.
    Okabe S; Fukuda T; Ishibashi K; Kojima S; Okada S; Hatano M; Ebara M; Saisho H; Tokuhisa T
    Mol Cell Biol; 1998 Jul; 18(7):4235-44. PubMed ID: 9632807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.
    Pero R; Palmieri D; Angrisano T; Valentino T; Federico A; Franco R; Lembo F; Klein-Szanto AJ; Del Vecchio L; Montanaro D; Keller S; Arra C; Papadopoulou V; Wagner SD; Croce CM; Fusco A; Chiariotti L; Fedele M
    J Biol Chem; 2012 May; 287(22):18308-17. PubMed ID: 22493480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The endless complexity of lymphocyte differentiation and lymphomagenesis: IRF-4 downregulates BCL6 expression.
    Lossos IS
    Cancer Cell; 2007 Sep; 12(3):189-91. PubMed ID: 17785200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.
    Ahmad KF; Melnick A; Lax S; Bouchard D; Liu J; Kiang CL; Mayer S; Takahashi S; Licht JD; Privé GG
    Mol Cell; 2003 Dec; 12(6):1551-64. PubMed ID: 14690607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
    Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
    Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.
    Lai AY; Fatemi M; Dhasarathy A; Malone C; Sobol SE; Geigerman C; Jaye DL; Mav D; Shah R; Li L; Wade PA
    J Exp Med; 2010 Aug; 207(9):1939-50. PubMed ID: 20733034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.
    Hatzi K; Jiang Y; Huang C; Garrett-Bakelman F; Gearhart MD; Giannopoulou EG; Zumbo P; Kirouac K; Bhaskara S; Polo JM; Kormaksson M; MacKerell AD; Xue F; Mason CE; Hiebert SW; Prive GG; Cerchietti L; Bardwell VJ; Elemento O; Melnick A
    Cell Rep; 2013 Aug; 4(3):578-88. PubMed ID: 23911289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
    Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
    Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.
    Batlle-López A; Cortiguera MG; Rosa-Garrido M; Blanco R; del Cerro E; Torrano V; Wagner SD; Delgado MD
    Oncogene; 2015 Jan; 34(2):246-56. PubMed ID: 24362533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus.
    Papadopoulou V; Postigo A; Sánchez-Tilló E; Porter AC; Wagner SD
    Biochem J; 2010 Apr; 427(3):541-50. PubMed ID: 20175752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of gene perturbation assay and ChIP-chip reveals functional direct target genes for IRF8 in THP-1 cells.
    Kubosaki A; Lindgren G; Tagami M; Simon C; Tomaru Y; Miura H; Suzuki T; Arner E; Forrest AR; Irvine KM; Schroder K; Hasegawa Y; Kanamori-Katayama M; Rehli M; Hume DA; Kawai J; Suzuki M; Suzuki H; Hayashizaki Y
    Mol Immunol; 2010 Aug; 47(14):2295-302. PubMed ID: 20573402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL6 represses Smad signaling in transforming growth factor-beta resistance.
    Wang D; Long J; Dai F; Liang M; Feng XH; Lin X
    Cancer Res; 2008 Feb; 68(3):783-9. PubMed ID: 18245479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.
    Baron BW; Anastasi J; Bies J; Reddy PL; Joseph L; Thirman MJ; Wroblewski K; Wolff L; Baron JM
    Blood Cells Mol Dis; 2014 Jan; 52(1):68-75. PubMed ID: 23910958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
    Chang CC; Ye BH; Chaganti RS; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6947-52. PubMed ID: 8692924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.